1 Study Coverage

• 1.1 S1P Receptor Modulator Drugs Revenue in S1P Receptor Modulator Drugs Business (2017-2022) & (US$ Million) Introduction
• 1.2 Global S1P Receptor Modulator Drugs Outlook 2017 VS 2022 VS 2028
• 1.2.1 Global S1P Receptor Modulator Drugs Market Size for the Year 2017-2028

1.2.2 Global S1P Receptor Modulator Drugs Market Size for the Year 2017-2028

1.3 S1P Receptor Modulator Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.3.1 The Market Share of United States S1P Receptor Modulator Drugs in Global, 2017 VS 2022 VS 2028

1.3.2 The Growth Rate of S1P Receptor Modulator Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.4 S1P Receptor Modulator Drugs Market Dynamics

1.4.1 S1P Receptor Modulator Drugs Industry Trends

1.4.2 S1P Receptor Modulator Drugs Market Drivers

1.4.3 S1P Receptor Modulator Drugs Market Challenges

1.4.4 S1P Receptor Modulator Drugs Market Restraints

1.5 Study Objectives

1.6 Years Considered

2 S1P Receptor Modulator Drugs by Type

• 2.1 S1P Receptor Modulator Drugs Market Segment by Type
• 2.1.1 Fingolimod

2.1.2 Ozanimod

2.1.3 Siponimod

2.1.4 Others

2.2 Global S1P Receptor Modulator Drugs Market Size by Type (2017, 2022 & 2028)

2.3 Global S1P Receptor Modulator Drugs Market Size by Type (2017-2028)

2.4 United States S1P Receptor Modulator Drugs Market Size by Type (2017, 2022 & 2028)

2.5 United States S1P Receptor Modulator Drugs Market Size by Type (2017-2028)

3 S1P Receptor Modulator Drugs by Application

• 3.1 S1P Receptor Modulator Drugs Market Segment by Application
• 3.1.1 Hospital Pharmacies

3.1.2 Retail Pharmacies

3.1.3 Online Pharmacies

3.1.4 Others

3.2 Global S1P Receptor Modulator Drugs Market Size by Application (2017, 2022 & 2028)

3.3 Global S1P Receptor Modulator Drugs Market Size by Application (2017-2028)

3.4 United States S1P Receptor Modulator Drugs Market Size by Application (2017, 2022 & 2028)

3.5 United States S1P Receptor Modulator Drugs Market Size by Application (2017-2028)

4 Global S1P Receptor Modulator Drugs Competitor Landscape by Company

• 4.1 Global S1P Receptor Modulator Drugs Market Size by Company
• 4.1.1 Top Global S1P Receptor Modulator Drugs Companies Ranked by Revenue (2021)

4.1.2 Global S1P Receptor Modulator Drugs Revenue by Player (2017-2022)

4.2 Global S1P Receptor Modulator Drugs Concentration Ratio (CR)

4.2.1 S1P Receptor Modulator Drugs Market Concentration Ratio (CR) (2017-2022)

4.2.2 Global Top 5 and Top 10 Largest Companies of S1P Receptor Modulator Drugs in 2021

4.2.3 Global S1P Receptor Modulator Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global S1P Receptor Modulator Drugs Headquarters, Revenue in S1P Receptor Modulator Drugs Business (2017-2022) & (US$ Million) Type

4.3.1 Global S1P Receptor Modulator Drugs Headquarters and Area Served

4.3.2 Global S1P Receptor Modulator Drugs Companies Revenue in S1P Receptor Modulator Drugs Business (2017-2022) & (US$ Million) Type

4.3.3 Date of International Companies Enter into S1P Receptor Modulator Drugs Market

4.4 Companies Mergers & Acquisitions, Expansion Plans

4.5 United States S1P Receptor Modulator Drugs Market Size by Company

4.5.1 Top S1P Receptor Modulator Drugs Players in United States, Ranked by Revenue (2021)

4.5.2 United States S1P Receptor Modulator Drugs Revenue by Players (2020, 2021 & 2022)

5 Global S1P Receptor Modulator Drugs Market Size by Region

• 5.1 Global S1P Receptor Modulator Drugs Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global S1P Receptor Modulator Drugs Market Size by Region (2017-2028)
• 5.2.1 Global S1P Receptor Modulator Drugs Market Size by Region: 2017-2022

5.2.2 Global S1P Receptor Modulator Drugs Market Size by Region (2023-2028)

6 Segment in Region Level & Country Level

• 6.1 North America
• 6.1.1 North America S1P Receptor Modulator Drugs Market Size YoY Growth 2017-2028

6.1.2 North America S1P Receptor Modulator Drugs Market Facts & Figures by Country (2017, 2022 & 2028)

6.1.3 United States

6.1.4 Canada

6.2 Asia-Pacific

6.2.1 Asia-Pacific S1P Receptor Modulator Drugs Market Size YoY Growth 2017-2028

6.2.2 Asia-Pacific S1P Receptor Modulator Drugs Market Facts & Figures by Region (2017, 2022 & 2028)

6.2.3 China

6.2.4 Japan

6.2.5 South Korea

6.2.6 India

6.2.7 Australia

6.2.8 China Taiwan

6.2.9 Indonesia

6.2.10 Thailand

6.2.11 Malaysia

6.3 Europe

6.3.1 Europe S1P Receptor Modulator Drugs Market Size YoY Growth 2017-2028

6.3.2 Europe S1P Receptor Modulator Drugs Market Facts & Figures by Country (2017, 2022 & 2028)

6.3.3 Germany

6.3.4 France

6.3.5 U.K.

6.3.6 Italy

6.3.7 Russia

6.4 Latin America

6.4.1 Latin America S1P Receptor Modulator Drugs Market Size YoY Growth 2017-2028

6.4.2 Latin America S1P Receptor Modulator Drugs Market Facts & Figures by Country (2017, 2022 & 2028)

6.4.3 Mexico

6.4.4 Brazil

6.4.5 Argentina

6.5 Middle East and Africa

6.5.1 Middle East and Africa S1P Receptor Modulator Drugs Market Size YoY Growth 2017-2028

6.5.2 Middle East and Africa S1P Receptor Modulator Drugs Market Facts & Figures by Country (2017, 2022 & 2028)

6.5.3 Turkey

6.5.4 Saudi Arabia

6.5.5 UAE

7 Company Profiles

• 7.1 Novartis International AG
• 7.1.1 Novartis International AG Company Details

7.1.2 Novartis International AG Business Overview

7.1.3 Novartis International AG S1P Receptor Modulator Drugs Introduction

7.1.4 Novartis International AG Revenue in S1P Receptor Modulator Drugs Business (2017-2022)

7.1.5 Novartis International AG Recent Development

7.2 Bristol Myers Squibb

7.2.1 Bristol Myers Squibb Company Details

7.2.2 Bristol Myers Squibb Business Overview

7.2.3 Bristol Myers Squibb S1P Receptor Modulator Drugs Introduction

7.2.4 Bristol Myers Squibb Revenue in S1P Receptor Modulator Drugs Business (2017-2022)

7.2.5 Bristol Myers Squibb Recent Development

7.3 Pfizer Inc.

7.3.1 Pfizer Inc. Company Details

7.3.2 Pfizer Inc. Business Overview

7.3.3 Pfizer Inc. S1P Receptor Modulator Drugs Introduction

7.3.4 Pfizer Inc. Revenue in S1P Receptor Modulator Drugs Business (2017-2022)

7.3.5 Pfizer Inc. Recent Development

7.4 Sanofi SA

7.4.1 Sanofi SA Company Details

7.4.2 Sanofi SA Business Overview

7.4.3 Sanofi SA S1P Receptor Modulator Drugs Introduction

7.4.4 Sanofi SA Revenue in S1P Receptor Modulator Drugs Business (2017-2022)

7.4.5 Sanofi SA Recent Development

7.5 Merck & Co., Inc.

7.5.1 Merck & Co., Inc. Company Details

7.5.2 Merck & Co., Inc. Business Overview

7.5.3 Merck & Co., Inc. S1P Receptor Modulator Drugs Introduction

7.5.4 Merck & Co., Inc. Revenue in S1P Receptor Modulator Drugs Business (2017-2022)

7.5.5 Merck & Co., Inc. Recent Development

7.6 Biogen Inc.

7.6.1 Biogen Inc. Company Details

7.6.2 Biogen Inc. Business Overview

7.6.3 Biogen Inc. S1P Receptor Modulator Drugs Introduction

7.6.4 Biogen Inc. Revenue in S1P Receptor Modulator Drugs Business (2017-2022)

7.6.5 Biogen Inc. Recent Development

7.7 Roche Holding AG

7.7.1 Roche Holding AG Company Details

7.7.2 Roche Holding AG Business Overview

7.7.3 Roche Holding AG S1P Receptor Modulator Drugs Introduction

7.7.4 Roche Holding AG Revenue in S1P Receptor Modulator Drugs Business (2017-2022)

7.7.5 Roche Holding AG Recent Development

8 Research Findings and Conclusion

9 Appendix

• 9.1 Research Methodology
• 9.1.1 Methodology/Research Approach

9.1.2 Data Source

9.2 Author Details

Market Analysis and Insights: Global and United States S1P Receptor Modulator Drugs Market
This report focuses on global and United States S1P Receptor Modulator Drugs market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global S1P Receptor Modulator Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Fingolimod accounting for % of the S1P Receptor Modulator Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital Pharmacies was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the S1P Receptor Modulator Drugs market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global S1P Receptor Modulator Drugs Scope and Market Size

S1P Receptor Modulator Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global S1P Receptor Modulator Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the S1P Receptor Modulator Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the S1P Receptor Modulator Drugs market is segmented into

Fingolimod

Ozanimod

Siponimod

Others

Segment by Application, the S1P Receptor Modulator Drugs market is segmented into

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Others

Regional and Country-level Analysis

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Landscape and S1P Receptor Modulator Drugs Market Share Analysis

S1P Receptor Modulator Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in S1P Receptor Modulator Drugs business, the date to enter into the S1P Receptor Modulator Drugs market, Revenue in S1P Receptor Modulator Drugs Business (2017-2022) & (US$ Million) introduction, recent developments, etc.

The major vendors covered:

Novartis International AG

Bristol Myers Squibb

Pfizer Inc.

Sanofi SA

Merck & Co., Inc.

Biogen Inc.

Roche Holding AG